Island Pharmaceuticals Ltd Cash Flow-to-Debt Ratio
Island Pharmaceuticals Ltd cash flow-to-debt ratio. Island Pharmaceuticals Ltd (ILA) has a Cash Flow-to-Debt Ratio of -5.03x as of June 2025, meaning its operating cash flow of AU$-1.69 Million could theoretically repay -5% of its total liabilities (AU$336.43K) in one year. See ILA free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Island Pharmaceuticals Ltd (2019–2024)
Cash flow-to-debt ratio of Island Pharmaceuticals Ltd from 2019 to 2024. Historical debt coverage capacity for Island Pharmaceuticals Ltd across 6 annual periods. Also explore Island Pharmaceuticals Ltd net asset momentum to track the company's year-over-year net asset growth rate.
Island Pharmaceuticals Ltd Cash Flow-to-Debt Ratio by Year (2019–2024)
Island Pharmaceuticals Ltd cash flow-to-debt ratio by year from 2019 to 2024. Year-by-year debt coverage analysis for Island Pharmaceuticals Ltd. For the full cash flow conversion analysis, see Island Pharmaceuticals Ltd (ILA) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -8.23x | AU$-2.77 Million | AU$336.43K | ▼ -171.9% |
| 2023 | -3.03x | AU$-3.16 Million | AU$1.05 Million | ▲ +70.5% |
| 2022 | -10.27x | AU$-2.71 Million | AU$263.85K | ▼ -217.5% |
| 2021 | -3.23x | AU$-1.88 Million | AU$580.73K | ▲ +18.4% |
| 2020 | -3.96x | AU$-938.24K | AU$236.83K | ▼ -16588.4% |
| 2019 | -0.02x | AU$-16.00 | AU$674.00 | — |